18 completed. 18 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 18 | Completed 18 |
Follow PATH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of a Multi-dose Regimen of Mebendazole Against Hookworm in Children Treatment with one of the two regimens of mebendazole - Hookworm | Phase 4 | Completed | Jennifer Keiser | 186 | 2017-07-25 | 2019-06-17 |
| Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine Live attenuated SA 14-14-2 Japanese Encephalitis vaccine, Measles, mumps, rubella vaccine - Encephalitis, Japanese, Measles | Phase 4 | Completed | PATH | 628 | 2016-10-13 | 2020-10-14 |
| Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration Reactive Focal Drug Administration - Malaria | Phase 4 | Completed | PATH | 8682 | 2016-02-01 | 2021-02-04 |
| Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts Case investigation of malaria passively detected cases with FT/FDA - Malaria | Phase 4 | Completed | PATH | 20379 | 2015-09-01 | 2016-09-15 |
| Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose Live Attenuated Japanese Encephalitis SA-14-14-2 Vaccine - Encephalitis, Japanese | Phase 4 | Completed | PATH | 561 | 2015-07-30 | 2020-10-19 |
| Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali pentavalent rotavirus vaccine (PRV), measles vaccine (MV), yellow fever vaccine (YFV) - Diarrhea Rotavirus | Phase 4 | Completed | PATH | 600 | 2014-10-01 | 2019-01-02 |
| Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children MMR vaccine - Immune Response to MMR Vaccine | Phase 4 | Completed | Serum Institute of India Pvt. Ltd. | 341 | 2014-09-01 | 2018-03-14 |
| Coadministration of Measles-rubella and Rotavirus Vaccines Rotarix vaccine, measles-rubella vaccine - Measles Antibody Seroconversion, Rubella Antibody Seroconversion | Phase 4 | Completed | PATH | 482 | 2013-01-01 | 2019-03-13 |
| Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana Human Rotavirus Vaccine - Rotavirus Gastroenteritis | Phase 4 | Completed | PATH | 456 | 2012-09-01 | 2015-06-01 |
| Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines Probiotic, Zinc, Probiotic placebo - Immunity to Oral Rotavirus Vaccine, Immunity to Oral Polio Vaccine | Phase 4 | Completed | PATH | 620 | 2012-07-01 | 2018-12-26 |
| A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 Live attenuated Japanese encephalitis vaccine SA14-14-2 - Japanese Encephalitis, Japanese Encephalitis Vaccine | Phase 4 | Completed | Indian Institute of Science | 17 | 2012-05-01 | 2019-04-26 |
| Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine Vaccine produced in existing facility, Vaccine produced in new facility - Japanese Encephalitis | Phase 4 | Completed | PATH | 818 | 2012-05-01 | 2018-12-05 |
| Immunogenicity of Rotavirus Vaccine Rotavirus vaccine - Rotavirus Gastroenteritis | Phase 4 | Completed | PATH | 1140 | 2011-04-01 | 2013-08-30 |
| Inactivated Influenza Vaccine Effectiveness in Tropical Africa seasonal trivalent inactivated influenza vaccine, inactivated polio vaccine - Influenza | Phase 4 | Completed | PATH | 10000 | 2009-05-01 | 2013-09-23 |
| Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab Rotavirus Vaccine (ROTARIX) - Rotavirus Gastroenteritis | Phase 4 | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | 4550 | 2008-09-01 | 2011-06-28 |
| Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis Paromomycin sulfate - Visceral Leishmaniasis | Phase 4 | Completed | PATH | 2000 | 2007-10-01 | 2014-10-03 |
| Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine (LJEV) - Japanese Encephalitis | Phase 4 | Completed | PATH | 305 | 2007-07-09 | 2020-03-31 |
| Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine, Live, attenuated measles vaccine - Japanese Encephalitis | Phase 4 | Completed | PATH | 278 | 2007-07-07 | 2019-02-08 |
Encephalitis, Japanese (6) · Malaria (2) · Ancylostomiasis (1) · Breast Feeding (1) · Diarrhea (1) · Flavivirus Infections (1) · Influenza, Human (1) · Leishmaniasis, Visceral (1) · Measles (1) · Mumps (1) · Poliomyelitis (1) · Rubella (1)
RIX4414 vaccine (5) · Rotavirus Vaccines (4) · Measles-Mumps-Rubella Vaccine (2) · Measles Vaccine (1) · Paromomycin (1) · Poliovirus Vaccine, Inactivated (1) · Poliovirus Vaccine, Oral (1) · Probiotics (1) · RotaTeq (1) · Therapeutics (1) · Yellow Fever Vaccine (1) · Zinc (1) · vaxigrip (1)
India (4) · Bangladesh (3) · Senegal (2) · Sri Lanka (2) · Ghana (1) · Mali (1) · Pakistan (1) · Philippines (1) · Tanzania (1) · Zambia (1)
Nihal Abeysinghe, MD, MSc (2) · Aldiouma Diallo, MD (1) · Amrendra K Aditya, MD (1) · Ashish Bavdekar, MD (1) · C P Thakur, MD (1) · Daniel Bridges, PhD (1) · Devendra Nath, MD (1) · Dr V Ravi, MBBS MD (1) · Gagandeep Kang, MD, PhD (1) · George Armah, PhD (1) · Jennifer Keiser, PhD (1) · Jitendra Oswal, MD (1) · John C Victor, PhD, MPH (1) · K Zaman, MBBS, PhD (1) · K Zaman, MD (1)
PMID 25239483, PMID 26035743, PMID 26823335, PMID 26823338, PMID 28135273, PMID 28419095, PMID 29395526, PMID 29659924, PMID 30689757, PMID 31193620, PMID 33165566, PMID 35243320, PMID 36962857